Research Reactivation Update
Updated January 13, 2022
COVID-19 boosters are now required by Feb. 1. - read the full announcement.
Booster clinics to be offered on Jan. 17, Jan. 26 and Jan. 31 at the Breslin Center - learn more and make an appointment.
General Research - COVID Safety Reminders
- Remember that it is critical and still a requirement for everyone to wear a well fitting mask.
- If you don’t need to be in the lab/studio/office, please work remotely.
- Be considerate about planning group gatherings/meetings (Is the meeting necessary? Can it be done virtually?).
- If you have COVID-19 symptoms or test positive, do not come to the lab/studio (get tested or if positive, please call the COVID-19 Triage Line at 855-958-2678 for guidance). Return to normal activities in the lab/studio after 5 days (of a positive test) only if you have no symptoms or your symptoms are resolving, and you do not have a fever.
- All information should be kept confidential between the individual, the PI/supervisor, and the chair/director However, after speaking with the COVID-19 Triage Line, positive individuals may contact those who have been identified as close contacts if they feel comfortable doing so.
- Report concerns, questions, or comments to your supervisor, or to MSU Environmental Health & Safety at 517-355-0153.
- You may also access the MSU Misconduct Hotline. The University prohibits retaliation against any individual who makes a report in good faith of known or suspected misconduct.
Human Research and COVID-19
All in-person interactions with research participants by MSU employees, MSU students, or agents of MSU must follow current COVID-19 university requirements. In addition, where applicable, follow any local site requirements including facility (e.g., school, hospital) and city, state, or country requirements.
- The Principal Investigator (PI) remains responsible for implementing and monitoring changes to COVID-19 control strategies to avoid increased risk to participants and assuring that the research team has appropriate staffing, resources, and training to support in-person interactions with research participants.
- When possible, researchers should consider use of remote technology instead of in-person interactions, especially in areas of high COVID-19 transmission.
- If the in-person interactions cannot be done remotely, researchers should consider whether it may be appropriate to delay or pause in person interactions with human participants, especially in areas of high COVID-19 transmission and where there is no direct benefit to the participants.
- Visit the Together We Will website for current MSU COVID-19 requirements.
- Visit the HRPP COVID-19 website for information about human research (e.g. when are modifications required for COVID-19 changes):
- If you have questions about MSU requirements for face masks or vaccination, please contact the University Physician (Tel: 517-353-8933; email: firstname.lastname@example.org).
- Feel free to contact EHS (517) 353-1877 or email@example.com to assist with any questions you may have.
- If you have other COVID-19 questions related to MSU human research, please contact Judy McMillan (firstname.lastname@example.org).
If you have any questions, please contact the Office of Research and Innovation at 517-355-0306.
For emergency issues, please reach out to the appropriate unit listed in the left menu.
|Research Under Lifted Restrictions||July 06, 2021|
|Research Under New On-Site Work Framework||June 10, 2021|
|Safety Reminders and Important Updates||December 04, 2020|
|Research Safety Reminders||November 16, 2020|
|Undergraduate Participation in Research Fall Semester 2020||September 10, 2020|
|Building Safety Plan Information||August 17, 2020|
|Research Safety Compliance Reporting||July 17, 2020|
|Reactivation of On-Site Research: Governor's Latest Executive Order 2020-90||May 15, 2020|
|New Online Health Screening Form - Memo to DDC & CORD||April 10, 2020|
|Research Continuity and Governor's Executive Order||March 23, 2020|
|Novel Coronavirus / COVID-19 and MSU Research Continuity - SUPERSEDED||March 17, 2020|
|Research Continuity Memo to Faculty and DDC - SUPERSEDED||March 16, 2020|